The Role of Liquid Biopsies in Detecting Molecular Tumor Biomarkers in Brain Cancer Patients
Heena Sareen(UNSW Sydney), Therese M. Becker(Liverpool Hospital), Branka Powter(Ingham Institute), Paul de Souza(St. George Hospital), Eng‐Siew Koh(Liverpool Hospital), Joseph W. Po(Camden and Campbelltown Hospitals), Mark Sheridan(Liverpool Hospital), David T. Lynch(Mayo Clinic in Arizona), Tara L. Roberts(Camden and Campbelltown Hospitals), Daniel Brungs(University of Wollongong), Joey Yusof Vessey(Liverpool Hospital), Renata Bazina(Liverpool Hospital), James van Gelder(Liverpool Hospital), Mathias Jaeger(Wollongong Hospital), Balsam Darwish(Liverpool Hospital), Adam Cooper(Liverpool Hospital), Simon McKechnie(Liverpool Hospital), Celine Garrett(Ingham Institute)
Cited by 43
Related Papers
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
|The Lancet Oncology|2015|1.4k
HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA
|Science|2009|822
AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC
|Cell Death and Differentiation|2013|507